1Bartholomeusz C,Itamochi H,Yuan LX,et al.bcl-2 antisense oligonucleotide overcomes resistance to E1A gene therapy in a low HER2-expressing ovarian cancer xenograft model[J].Cancer Res,2005,65(18):8406
2Belanger S,Cote M,Lane D,et al.bcl-2 decreases cell proliferation and promotes accumulation of cells in S phase without affecting the rate of apoptosis in human ovarian carcinoma cells[J].Gynecol Oncol,2005,97(3):796
3Rodina AV,Sladkova LV,Obukhova VV,et al.Inactivation and sensitization of the tumor cells by the gene Bax transfection[J].Mol Biol (Mosk),2005,39(1):40
4Strait KA,Warnick CT,Ford CD,et al.Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the bcl-2-related protein Bad[J].Mol Cancer Ther,2005,4(4):603
5Bali A,O′Brien PM,Edwards LS,et al.Cyclin D1,p53,and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer[J].Clin Cancer Res,2004,10(15):5168
6Terauchi F,Okamoto A,Nagashima T,et al.Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary[J].Oncol Rep,2005,14(2):363
7Tsuda H,Bandera CA,Birrer MJ,et al.Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary[J].Oncology,2004,67(3-4):291
8Aghmesheh M,Nesland JM,Kaern J,et al.No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers[J].Gynecol Oncol,2004,95(3):430
10Ferrandina G,Legge F,Martinelli E,et al.Survivin expression in ovarian cancer and its correlation with clinico-pathological,surgical and apoptosis-related parameters[J].Br J Cancer,2005,92(2):271
3Ikeguehi M, Kaibara N. Survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma [J]. Br J Cancer, 2002, 87(8):883-887.
4Kim HS, Shiraki K, Park SH. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix [J]. Anticancer Res, 2002, 22(2A):805-808.
5Nasu S, Yagihashi A, Izawa A, et al. Survivin mRNA expression in patients with breast cancer [J]. Anticancer Res, 2002, 22(3): 1839 - 1843.
6Yu J, Leung WK, Ebert MP, et al. Increased expression of survivin in gastric cancer patients and in first degree relatives[J]. Br J Cancer, 2002, 87(1): 91-97.
7Sui L, Dong Y, Ohno M. el al. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors [J]. Int J Oncol, 2002, 21(2): 315 -320.
8Hay BA. Understanding 1AP function and regulation: a view from Drosophila [J]. Cell Death & Differ, 2000, 7:1045 - 1056.
9Harfouche R, Hassessian HM, Guo Y, et al. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells [J]. Microvasc Res, 2002, 64(1): 135 - 147.
10Suzuki A, lto T, Kawano H. et al. Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death [J]. Oncogene, 2000, 19(10):1346 - 1353.
